End of an ERA: Lessons from negative clinical trials in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 1, 2011, Pages 4-5

  Noble, Paul W ^a   Richeldi, Luca ^b   Kaminski, Naftali ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; GAMMA INTERFERON; GAMMA1B INTERFERON; PLACEBO; PREDNISOLONE;

CLINICAL RESEARCH; DRUG EFFICACY; EDITORIAL; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; PRIORITY JOURNAL; SURVIVAL;

ANTIHYPERTENSIVE AGENTS; ENDPOINT DETERMINATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; RECEPTORS, ENDOTHELIN; SULFONAMIDES; TREATMENT OUTCOME;

EID: 80051569670     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201105-0813ED     Document Type: Editorial

References (5)

1. King TE Jr., Brown KK, Raghu G, du Bois RM, Lynch D, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. Bosentan use in interstitial lung disease-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2011;183:92-99.
2. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-1269. (Pubitemid 29489741)
3. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl JMed 2004;350:125-133. (Pubitemid 38056223)
4. King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicenter, randomized, placebo-controlled trial. Lancet 2009;374:222-228.
5. King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stahler G, Leconte I, Roux S, Raghu G. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177:75-81.